Phthalate Exposure in Association with Amyloid-β42, T-tau and P-T181-tau in Plasma L1CAM Exosomes and Cerebrospinal Fluid in Parkinson's Disease with Mild Cognitive Impairment

Jing Zou,Jiaqi Xu,Zhe Deng,Lei Wei,Lingling Wu,Xiaodong Zhuang,Anding Xu,Yue Guo

DOI: https://doi.org/10.2139/ssrn.4087602

2022-01-01

Abstract:Background: The major pathological feature of Parkinson’s disease with mild cognitive impairment (PD-MCI) is closely associated with the hallmarks of Alzheimer's disease (AD) neuropathy (e.g. amyloid-β and tau). The potential intervention of environmental factors in PD-MCI pathogenesis has garnered increasing attention. However, no study has determined whether exposure to environmental phthalate contributes to regulating the biomarkers in plasma neuronal-derived L1CAM exosomes and cerebrospinal fluid (CSF) of patients with PD-MCI.Methods: We enrolled a total of 120 healthy participants, 127 patients with PD having normal cognition (PD-normal) and 118 patients with PD-MCI. We used fluorescence nanoparticle tracking analysis (NTA) and an ultrasensitive methodology combined with Quanterix Simoa to evaluate the concentrations of Aβ42, T-tau, and P-T181-tau in L1CAM exosomes. High-performance liquid chromatography and tandem mass spectrometry were performed to evaluate urinary phthalate metabolites. The relationship between urinary phthalate metabolites and the concentrations of Aβ42, T-tau, and P-T181-tau in L1CAM exosomes and CSF were determined using generalized linear models (GLMs).Results: We found that MEOHP, MEHHP, and MEHP increased and MBzP decreased in the PD-MCI group and the PD-MCI subgroups positive for CSF Aβ42 and tau. Higher MEOHP, MEHHP, MEHP, and lower MBzP were not only associated with these biomarkers in L1CAM exosomes but also strongly associated with these biomarkers in CSF of patients with PD-MCI. Moreover, we found that higher MEOHP, MEHHP, MEHP, and lower MBzP were associated with lower values of six cognitive domains (attention, delay recall, orientation, language, visuospatial/executive function, and abstraction), except for the naming domain.Conclusions: This is the first study to show an association between urinary phthalate metabolites and biomarkers in plasma L1CAM exosomes and CSF of PD-MCI pathophysiology. The identification of phthalate metabolites can be useful to elucidate the mechanism underlying the co-pathologies of PD-MCI and help in the development of potential novel therapies.